Search by Drug Name or NDC
NDC 31722-0215-01 Daptomycin 350 mg/7mL Details
Daptomycin 350 mg/7mL
Daptomycin is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is DAPTOMYCIN.
Product Information
| NDC | 31722-0215 |
|---|---|
| Product ID | 31722-215_f16ae2ef-72ac-19ba-e053-2995a90a629b |
| Associated GPIs | |
| GCN Sequence Number | 060477 |
| GCN Sequence Number Description | daptomycin VIAL 350 MG INTRAVEN |
| HIC3 | W9B |
| HIC3 Description | CYCLIC LIPOPEPTIDES |
| GCN | 26638 |
| HICL Sequence Number | 025673 |
| HICL Sequence Number Description | DAPTOMYCIN |
| Brand/Generic | Generic |
| Proprietary Name | Daptomycin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Daptomycin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 350 |
| Active Ingredient Units | mg/7mL |
| Substance Name | DAPTOMYCIN |
| Labeler Name | Camber Pharmaceuticals, Inc. |
| Pharmaceutical Class | Lipopeptide Antibacterial [EPC], Lipopeptides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216445 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 31722-0215-01 (31722021501)
| NDC Package Code | 31722-215-01 |
|---|---|
| Billing NDC | 31722021501 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (31722-215-01) / 7 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-12-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |